You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Amneal Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for AMNEAL PHARM, and what generic and branded alternatives to AMNEAL PHARM drugs are available?

AMNEAL PHARM has two hundred and twenty-five approved drugs.

There are five tentative approvals on AMNEAL PHARM drugs.

Summary for Amneal Pharm

US Patents:	0
Tradenames:	177
Ingredients:	172
NDAs:	225
Patent Litigation for Amneal Pharm:	See patent lawsuits for Amneal Pharm
PTAB Cases with Amneal Pharm as petitioner:	See PTAB cases with Amneal Pharm as petitioner

Drugs and US Patents for Amneal Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Amneal Pharms Co	DESIPRAMINE HYDROCHLORIDE	desipramine hydrochloride	TABLET;ORAL	208105-001	Mar 17, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET, EXTENDED RELEASE;ORAL	207515-001	Feb 1, 2018		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms	ARIPIPRAZOLE	aripiprazole	TABLET;ORAL	204838-006	Jun 17, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms	WARFARIN SODIUM	warfarin sodium	TABLET;ORAL	202202-002	Mar 4, 2013	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms Co	PREGABALIN	pregabalin	CAPSULE;ORAL	209743-007	Jul 19, 2019	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms	LACOSAMIDE	lacosamide	TABLET;ORAL	204857-003	Mar 17, 2022	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Amneal Pharms	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	204382-002	Aug 11, 2023	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for AMNEAL PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.